Dr. Jun He | Stem Cell Therapy | Best Researcher Award

The First Affiliated Hospital of Soochow University | China

Author Profile

Dr. Jun He appears to be a highly suitable candidate for the Research for Community Impact Award based on several key factors:

Extensive Professional Experience:

Leadership: Dr. He has been the Director of the HLA typing laboratory at the Jiangsu Institute of Hematology since 2010. This role indicates a significant leadership position within an influential research institution.
Long-term Commitment: Dr. He has held continuous positions of increasing responsibility at the same institution since 1985, showcasing dedication and consistent contribution to his field.

Educational Background:

Dr. He has a robust educational foundation in medicine, with both an M.D. and a B.S. from prestigious institutions in China (Soochow University and Suzhou Medical College).

Impactful Research:

Publication Record: Dr. He has published extensively in reputable peer-reviewed journals, with 33 listed publications. These papers cover critical aspects of HLA typing, stem cell transplantation, immunogenetics, and related fields, demonstrating significant contributions to medical science and community health.
Research Focus: His research on the genetic loci of HLA, KIRs, and their impact on transplantation outcomes is crucial for improving the success rates and safety of hematopoietic stem cell transplants, a vital area for many patients with hematological malignancies.

Professional Recognition and Membership:

Council Memberships: Dr. He has served as a Council Member for both the Experts Committee of the China Marrow Donor Program and The Chinese Medical Society of Organ Transplantation, indicating peer recognition and trust in his expertise.
International Membership: His membership in the American Society of Histocompatibility and Immunogenetics shows his engagement with the global scientific community.

Community Impact:

Marrow Donor Program: His long-term involvement with the China Marrow Donor Program reflects his commitment to enhancing donor registries and improving transplantation outcomes, directly benefiting patients and the broader community.
Training and Mentorship: As a Doctoral Supervisor, Dr. He plays a significant role in training the next generation of medical professionals and researchers, amplifying his impact on community health.

Innovative Research Contributions:

NGS and mNGS: His recent work using next-generation sequencing (NGS) and metagenomic NGS for pathogen identification demonstrates his engagement with cutting-edge technologies to improve clinical decision-making and patient outcomes.

In conclusion, Dr. Jun He’s distinguished career, significant research contributions, leadership roles, and dedication to community health make him a highly deserving candidate for the Research for Community Impact Award.

📊🔬Notable Publication:

Utilizing Metagenomic Next-Generation Sequencing (mNGS) for Rapid Pathogen Identification and to Inform Clinical Decision-Making: Results from a Large Real-World Cohort

- Authors: Xu, J., Zhou, P., Liu, J., Ma, Y., He, J.
- Journal: Infectious Diseases and Therapy
- Year: 2023

Use of Next-Generation Sequencing to Detect Polymorphism of 11 HLA Allele Loci in the Chinese Han Population and Variance from Other Common and Well-Documented Lists

- Authors: Jiang, X., Yuan, X., Li, Y., Bao, X., He, J.
- Journal: HLA
- Year: 2023

Posttransplant de novo DSA and NDSA Affect GvHD, OS, and DFS after Haplo-HSCT in Patients Without Pre-existing HLA Antibodies of Hematological Malignancies

- Authors: Wang, L., Ji, K., Chen, L., Wu, X., He, J.
- Journal: Frontiers in Immunology
- Year: 2022

Splenic Irradiation Combined with Plasmapheresis and Rituximab: A New Option Reducing Donor-Specific Antibody in Haploidentical Hematopoietic Stem Cell Transplantation

- Authors: Zhou, S., Ma, X., Ma, C., Wu, X., Qin, S.
- Journal: Bone Marrow Transplantation
- Year: 2023

Role of Lipid Metabolism in Hepatocellular Carcinoma

- Authors: Cheng, Y., He, J., Zuo, B., He, Y.
- Journal: Discover Oncology
- Year: 2024

Introduction: Embark on a journey of empowerment and innovation with the Leadership in Advancing Women’s Health in Oncology Award. This distinguished accolade honors trailblazing individuals committed to driving progress and excellence in the realm of women's health within the field of oncology.

Award Eligibility: This award is open to exceptional leaders, researchers, and advocates globally, without age restrictions. Candidates should hold a significant role in women’s health in oncology, showcasing a profound commitment to advancing research, education, and awareness.

Evaluation Criteria: Candidates will be evaluated based on their leadership impact, demonstrated advancements in women’s health in oncology, and a track record of publications reflecting their commitment to the cause. Recognition within the scientific community and beyond will also be considered.

Submission Guidelines: Applicants are required to submit a comprehensive biography, an abstract of their work, and supporting files that illuminate their leadership and contributions to women’s health in oncology. Submissions should adhere to specified format guidelines outlined in the submission instructions.

Recognition and Community Impact: This award not only celebrates individual leadership but also recognizes the broader impact of the recipient's work on the community and society. Awardees will be acknowledged in prominent events and publications, amplifying the influence of their contributions.